Nu Skin Enterprises (NYSE:NUS – Get Free Report) and Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends.
Profitability
This table compares Nu Skin Enterprises and Dermata Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nu Skin Enterprises | -15.73% | 6.58% | 3.63% |
| Dermata Therapeutics | N/A | -166.66% | -130.13% |
Valuation & Earnings
This table compares Nu Skin Enterprises and Dermata Therapeutics”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nu Skin Enterprises | $1.38 billion | 0.17 | $160.20 million | ($4.47) | -1.08 |
| Dermata Therapeutics | N/A | N/A | -$7.56 million | ($4.39) | -0.29 |
Nu Skin Enterprises has higher revenue and earnings than Dermata Therapeutics. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Dermata Therapeutics, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 8.7% of Dermata Therapeutics shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Comparatively, 21.9% of Dermata Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Risk & Volatility
Nu Skin Enterprises has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Dermata Therapeutics has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Nu Skin Enterprises and Dermata Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nu Skin Enterprises | 2 | 0 | 0 | 0 | 1.00 |
| Dermata Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Summary
Nu Skin Enterprises beats Dermata Therapeutics on 6 of the 10 factors compared between the two stocks.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
About Dermata Therapeutics
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
